Sponsor or institution

Clinical trials and research at Fujian Shengdi Pharmaceutical Co., Ltd.

• 16Clinical trials
• 1Country

Newest trials

All recruiting trials (16)

• Single-dose PK study of HRS-4729 in adults with and without kidney impairment

  This study tests a single dose of HRS-4729 to see how the body handles it in adults with various levels of kidney function compared with healthy adults.

  Recruiting Phase 1 Fujian Shengdi Pharmaceutical Co., Ltd. · Chengdu, Sichuan · NCT07807059

• HRS-4139 safety and pharmacology in healthy adults

  This early-phase study tests a single dose of HRS-4139 to see if it is safe and how the body handles it in healthy adults aged 18–55.

  Recruiting Phase 1 Fujian Shengdi Pharmaceutical Co., Ltd. · Changsha, Hunan · NCT07802964

• HRS-7249 extension study for people with high triglycerides

  This extension study tests whether repeat injections of HRS-7249 are safe and keep triglyceride levels low in adults who previously completed the parent study or have high fasting triglycerides.

  Recruiting at 2 sites Phase 2 Fujian Shengdi Pharmaceutical Co., Ltd. · Jinan, Shandong and 1 other locations · NCT07799688

• HRS5580 plus palonosetron to prevent postoperative nausea and vomiting

  This study tests whether HRS5580 given with palonosetron can prevent nausea and vomiting after surgery in adults undergoing certain procedures.

  Recruiting at 2 sites Phase 2 Fujian Shengdi Pharmaceutical Co., Ltd. · Shanghai, Shanghai Municipality and 1 other locations · NCT07709897

• HRS9531 tablets vs placebo for weight loss in adults with overweight or obesity

  This study tests whether HRS9531 tablets help people who are overweight or obese lose weight over a year, compared with a placebo.

  Recruiting at 2 sites Phase 3 Fujian Shengdi Pharmaceutical Co., Ltd. · Zhengzhou, Henan and 1 other locations · NCT07670884

• HRS-4729 and HRS9531 injections in adults with MASH

  This study tests whether HRS-4729 and HRS9531 injections (and their placebos) can help adults with metabolic dysfunction-associated steatohepatitis after 52 weeks of treatment.

  Recruiting at 2 sites Phase 2 Fujian Shengdi Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality and 1 other locations · NCT07660848

• HRS-5635 in people with chronic hepatitis B who are suppressed on nucleos(t)ide analogues

  A Phase 3 study tests whether HRS-5635 injections cause better viral suppression and safety than placebo in people with chronic hepatitis B who already have low HBV DNA and are on stable NA therapy.

  Recruiting Phase 3 Fujian Shengdi Pharmaceutical Co., Ltd. · Guangzhou, Guangzhou · NCT07606950

• HRS9531 tablets for adults with type 2 diabetes not controlled by lifestyle or metformin

  This trial tests whether HRS9531 tablets help people with type 2 diabetes who have not reached their blood sugar goals on lifestyle changes or on metformin alone.

  Recruiting at 2 sites Phase 2 Fujian Shengdi Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality and 1 other locations · NCT07599410

• HRS9531 for atherosclerotic cardiovascular disease

  This study tests whether HRS9531, compared with placebo, can reduce major adverse cardiovascular events in people with ASCVD.

  Recruiting Phase 3 Fujian Shengdi Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality · NCT07551492

• HRS9531 PK in adults with different liver function

  This Phase 1 study tests how HRS9531 behaves in the body and whether it is safe in people with mild, moderate liver impairment and those with normal liver function.

  Recruiting Phase 1 Fujian Shengdi Pharmaceutical Co., Ltd. · Zhengzhou, Henan · NCT07540754

• Phase II HRS-9057 injection for heart failure-related fluid buildup

  This Phase II study will test whether HRS-9057 injections help adults hospitalized with heart failure who still have fluid buildup despite loop diuretics.

  Recruiting Phase 2 Fujian Shengdi Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality · NCT07318103

• Comparing first- and second-generation HRS9531 tablets in people with overweight or obesity

  This study will test whether the second-generation HRS9531 tablet is absorbed differently and is as safe and tolerable as the first-generation tablet in adults who are overweight or obese.

  Recruiting Phase 1 Fujian Shengdi Pharmaceutical Co., Ltd. · Hefei, Anhui · NCT07150962

• HRS9531 added to basal insulin for people with type 2 diabetes

  This test will see if adding HRS9531 to basal insulin helps lower blood sugar more than a placebo in people with type 2 diabetes whose glucose is not well controlled on basal insulin.

  Recruiting Phase 3 Fujian Shengdi Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality · NCT07060456

• HRS9531 injection for obstructive sleep apnea in adults with obesity

  This trial will test whether injections of HRS9531 can lower sleep apnea severity in adults with obesity.

  Recruiting Phase 3 Fujian Shengdi Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality · NCT06974851

• Testing HRS-5817 injections for safety in adults with obesity

  This will test whether subcutaneous HRS-5817 injections are safe and how the body processes them in adults with obesity.

  Recruiting Phase 1 Fujian Shengdi Pharmaceutical Co., Ltd. · Hefei, Anhui · NCT06934408

• Evaluating HRS-5635 Injection for Chronic Hepatitis B Treatment

  This study is testing if an injection called HRS-5635 can help people with chronic hepatitis B feel better when used alone or with other treatments.

  Recruiting Phase 2 Fujian Shengdi Pharmaceutical Co., Ltd. · Guangzhou, Guangdong · NCT06425341

Quick answers

How many clinical trials run by Fujian Shengdi Pharmaceutical Co., Ltd. are recruiting right now?

16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Phase 1: 5, Phase 3: 5. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →